Related Experiment Video
Updated: May 25, 2026

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
Published on: September 30, 2021
Getting rid of refractory hemophilia
1IRCCS Ca' Granda Maggiore Policlinico Hospital Foundation.
Abstract:
In a prospective randomized, multicenter study of immune tolerance induction(ITI) in patients with hemophilia A refractory to replacement therapy after the development of alloantibodies that inhibit factor VIII (FVIII) activity, Hay and DiMichele compared two regimens, a low dose of FVIII (50 IU/Kg thrice weekly)or a high-dose (200 IU/kg daily
Related Concept Videos
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
